The Glaucoma and Retinopathy Screening Study

Conditions studied

Glaucoma

About this study

The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field testing works to screen for glaucoma. Participants will: Have an image of their fundus (back of the eye) taken as part of their diabetic eye screening Have a measurement of their eye pressure If needed, have a test of their side vision using a headset

Interventions

• Device: AI-based glaucoma screening — AI analysis of fundus photographs to detect signs of glaucoma, added to AI-based diabetic eye disease screening
• Device: IOP measurement — Intraocular pressure measurement by Icare tonometer
• Device: Virtual Reality Visual Field Testing — Virtual Reality Visual Field Testing by the Olleyes device for participants suspected of having glaucoma

Primary outcomes

• Glaucoma detection (1 year from initial screening)

Eligibility information

Study locations

• Massachusetts General Hospital Internal Medicine Associates, Boston, Massachusetts 02114 United States
• Brigham and Women's Primary Care Associates of Longwood, Boston, Massachusetts 02115 United States
• Massachusetts General Hospital Broadway Primary Care-Revere, Boston, Massachusetts 02151 United States
• MGH Chelsea HealthCare Center, Chelsea, Massachusetts 02150 United States
• NSPG Lynn, Lynn, Massachusetts 01904 United States
• NSPG Salem, Salem, Massachusetts 01970 United States
• NSPG Saugus, Saugus, Massachusetts 01906 United States